J&J's DePuy can't dodge $8.3M metal hip implant verdict

May 27, 2013 by Arezu Sarvestani

Johnson & Johnson and its DePuy Orthopaedics subsidiary lose a bid to dismiss a $8.3 million loss in a patient injury lawsuit over the company's recalled metal-on-metal hip implants.

hip implant x-ray illustration

Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics is still responsible for an $8.3 million award to a patient who claimed the companies were responsible for injuries caused by recalled hip implants.

California Judge J. Stephen Czuleger rejected DePuy's request for a new trial, maintaining the jury decision handed down in March, which found that the company's metal-on-metal implants were defectively designed.

The medical device maker said last month that it would attempt to reverse the decision, which was the result of the 1st complaint to go to trial in the high-profile lawsuits over the implants.

Sign up to get our free newsletters delivered right to your inbox.

Judge Czuleger denied the attempt to appeal the ruling on the grounds that the plaintiff had provided enough evidence to establish that the products were defective in design, Law360.com reported.